IN2014MU00001A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00001A
IN2014MU00001A IN1MU2014A IN2014MU00001A IN 2014MU00001 A IN2014MU00001 A IN 2014MU00001A IN 1MU2014 A IN1MU2014 A IN 1MU2014A IN 2014MU00001 A IN2014MU00001 A IN 2014MU00001A
Authority
IN
India
Prior art keywords
chloroacetyl
preparation
present
provides
salicylamide
Prior art date
Application number
Inventor
G Sathe Dr Dhananjay
V Gawas Dr Dnyaneshwar
L Salunke Dr Chetan
Kapil R Raut Mr
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Priority to IN1MU2014 priority Critical patent/IN2014MU00001A/en
Publication of IN2014MU00001A publication Critical patent/IN2014MU00001A/en

Links

Abstract

The present invention provides an improved process for preparation of phenylalkylaminoethylsalicylamide, an adrenergic receptor blocking agent from 5-chloroacetyl salicylamide intermediate. The present invention also provides process for preparation of 5-chloroacetyl salicylamide intermediate.
IN1MU2014 2014-01-01 2014-01-01 IN2014MU00001A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1MU2014 IN2014MU00001A (en) 2014-01-01 2014-01-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1MU2014 IN2014MU00001A (en) 2014-01-01 2014-01-01

Publications (1)

Publication Number Publication Date
IN2014MU00001A true IN2014MU00001A (en) 2015-08-21

Family

ID=54393252

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1MU2014 IN2014MU00001A (en) 2014-01-01 2014-01-01

Country Status (1)

Country Link
IN (1) IN2014MU00001A (en)

Similar Documents

Publication Publication Date Title
PH12018500457A1 (en) New phenoxymethyl derivatives
MX2020005213A (en) Mk2 inhibitors and uses thereof.
PH12017500660A1 (en) Novel compositions, uses and methods for making them
MX2018016038A (en) Compounds and methods for modulating rna function.
MX2017006694A (en) Fused bicyclic compounds for the treatment of disease.
PH12017502237A1 (en) Nuclear receptor modulators
MX369600B (en) A disposable article including at least one elastic bonded region.
MX2023006415A (en) Antibodies, uses & methods.
PH12018500829A1 (en) Novel heterocyclic antiestrogens
MX2019000246A (en) Solid state forms of palbociclib dimesylate.
MX2020007742A (en) Processes for preparing fluoroketolides.
GB2540427B (en) Process for the preparation of 2,3,3,3-tetrafluoropropene (1234yf)
MX2017003288A (en) Methods of preparing toll-like receptor modulators.
MX2019004182A (en) Process for the manufacture of 2,6-dimethyl-5-hepten-1-al.
IN2014CH00304A (en)
MX2016015298A (en) Nampt inhibitors and methods.
EA201692246A1 (en) Method of producing 2,6-dimethylbenzoquinone
NZ721832A (en) Solid forms of tenofovir
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
CL2016002256A1 (en) An improved process for the preparation of exametazyme
MX2016017019A (en) Method for preparation of 4-alkoxy-1,1,1-trifluorobut-3-en-2- ones from 1,1,1-trifluoroacetone.
MX2016016398A (en) Preparation of piperidine-4-carbothioamide.
MX2017002609A (en) Improved process for the preparation of lacosamide and its novel intermediate.
IN2014MU00001A (en)
DK3493849T3 (en) New uses of n, n-bis-2-mercaptoethyl isophthalamide